Prognostic value of lymph node involvement in XXXX .

@entity43 @entity1 @entity13374
OBJECTIVE: This study was conducted to evaluate the prognosis value of lymph node involvement (LN positive) lymph node @entity43 (BOT). STUDY DESIGN: This was a retrospective study on 49 @entity1 treated at our institution for advanced-stage serous BOT (International @entity13374 [ @entity13374 ] III or IV). Pathological characteristics and survival were compared according to the lymph node status. The same analysis was performed on 1503 @entity1 of the Surveillance, Epidemiology, and End Results (SEER) database. RESULTS: In our institution, 14 @entity1 were LN positive. Eight @entity1 have been upstaged after lymph node dissection. No @entity1 has died during follow-up (median 53 months). LN positivity was not associated with recurrence. In the SEER registry, 93 @entity1 (6.2%) had LN positivity. These @entity1 were younger and with more advanced local extension. Survival curves were similar after adjustment for @entity13374 stage. CONCLUSION: Lymph node involvement does not appear as a prognosis factor for advanced-stage BOT.
